Session date: 
04/22/2021 - 7:30am to 8:30am

Learning Objectives
Upon conclusion of this program, participants should be able to:

  • Determine the epidemiologic risk factors for NDM-producing carbapenem-resistant Klebsiella pneumonia infection.
  • Describe the common mechanisms of antimicrobial resistance by NDM-producing CRE Klebsiella pneumonia.
  • ​​​​​​​Compare different therapeutic approaches in management of NDM-producing CRE bloodstream infection.



ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

    Presenter: 
    Isin Comba, MD
    Co-presenter: 
    Mikhaila L. Rice, PharmD, RPh
    Additional presenter: 
    Madiha Fida, MBBS
    Where did the idea for the course originate?: 
    Minnesota
    Please login or register to take this course.
    Where did the idea for the course originate?: 
    Minnesota